March 20, 2019

2018 Investment in Midwest Healthcare Companies Holds Steady at $2.5 Billion, Validating 43% 2017 Increase

Investment in Midwest healthcare companies remained steady in 2018, with $2.5 billion in capital raised by 438 companies. That amount of investment validates the record increase of 43% seen in 2017, demonstrating the sustained interest among investors in biomedical companies in the Midwest. These were the findings of the 2018 Midwest Healthcare Growth Capital Report, published annually by BioEnterprise, which tracks capital investments made in biomedical companies across 11 Midwestern states in three sectors – medical device; biotechnology and pharmaceuticals; and health IT/software and services.